Cogstate Ltd CGS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$3.40
- Day Range
- A$3.29–3.46
- 52-Week Range
- A$1.75–3.50
- Bid/Ask
- A$3.23 / A$3.35
- Shares Outstanding
- 171.99M
- Market Cap
- A$565.84M
- Volume/Avg
- 152,387 / 457,136
Key Statistics
- Price/Earnings (Normalized)
- 29.76
- Price/Sales
- 6.77
- Dividend Yield (Trailing)
- 1.22%
- Dividend Yield (Forward)
- 1.22%
- Dividend Payment Schedule
- Sep
- Total Yield
- 1.63%
Company Profile
Cogstate Ltd is engaged in the creation, validation, and commercialisation of digital brain health assessments and the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its solutions include Digital Cognitive Assessment, Endpoint Data Quality, Remote Assessment and Healthcare Cognitive Screening. Its operating segments are Clinical Trials, Healthcare, and Administration, with Clinical Trials generating maximum revenue. The Group provides licensed software to Clinical Trials and Healthcare customers, comprising access to the software.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 380
- Website
- https://www.cogstate.com
Valuation
|
Metric
|
CGS
|
|---|---|
Price/Earnings (Normalized) | 29.76 |
Price/Book Value | 6.60 |
Price/Sales | 6.77 |
Price/Cash Flow | 46.44 |
Price/Earnings
CGS
Financial Strength
|
Metric
|
CGS
|
|---|---|
Quick Ratio | 3.28 |
Current Ratio | 3.54 |
Interest Coverage | 841.67 |
Quick Ratio
CGS
Profitability
|
Metric
|
CGS
|
|---|---|
Return on Assets (Normalized) | 18.98% |
Return on Equity (Normalized) | 25.37% |
Return on Invested Capital (Normalized) | 23.97% |
Return on Assets
CGS
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|#Yb&kk!T | LOCK|kN> | $44B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|fs | $14B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|Z<KcT | $12B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|?yS?$ | $11B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|>g#>v | $11B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|PG>^ | $8B | |||
| HealthEquity Inc
HQY
| — | LOCK|!PX? | $7B | |||
| M3 Inc
MTHRF
| — | LOCK|<#HnF | $7B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|$%#$M | $7B | |||
| Doximity Inc Class A
DOCS
| — | LOCK|&< | $5B |
United States